Analysts at GlobalData report that the oncology drug market is tilting toward biologics, and that the total market for these drugs will continue to grow rapidly, reaching $786 billion by 2029.
https://www.pharmalive.com/wp-content/uploads/2023/11/chart-growth-laptopscreen.jpg450678BioSpacehttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngBioSpace2023-11-22 08:50:442023-11-22 09:09:43Biologics projected to keep gaining ground in cancer therapeutics market
